Rapid and safe response to low-dose carbamazepine in neonatal epilepsy

Epilepsia

Volumn 57, Issue 12, 2016, Pages 2019-2030

  Sands, Tristan T ^a,h   Balestri, Martina ^b   Bellini, Giulia ^c   Mulkey, Sarah B ^d   Danhaive, Olivier ^e   Bakken, Eliza Hayes ^e   Taglialatela, Maurizio ^f   Oldham, Michael S ^a,i   Vigevano, Federico ^b   Holmes, Gregory L ^g   Cilio, Maria Roberta ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MOLISE   (Italy)

^g UNIVERSITY OF VERMONT   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ University of Louisville School of Medicine   (United States)

Author keywords

Benign familial neonatal epilepsy; Carbamazepine; KCNQ2; KCNQ3; Neonatal seizures; Oxcarbazepine

Indexed keywords

CARBAMAZEPINE; OXCARBAZEPINE; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; SODIUM CHANNEL NAV1.2; ANTICONVULSIVE AGENT; POTASSIUM CHANNEL; SCN2A PROTEIN, HUMAN;

ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; DRUG SAFETY; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FAMILY HISTORY; FOLLOW UP; GENE DELETION; GENE MUTATION; HOSPITALIZATION; HUMAN; INFANTILE SPASM; MAINTENANCE THERAPY; MEDICAL HISTORY; MISSENSE MUTATION; NEWBORN; NEWBORN DISEASE; NONSENSE MUTATION; PRIORITY JOURNAL; TREATMENT RESPONSE; DIAGNOSTIC IMAGING; EPILEPSY, BENIGN NEONATAL; FAMILY HEALTH; FEMALE; GENETICS; GESTATIONAL AGE; INFANT; MALE; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD;

ANTICONVULSANTS; CARBAMAZEPINE; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; EPILEPSY, BENIGN NEONATAL; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; NAV1.2 VOLTAGE-GATED SODIUM CHANNEL; POTASSIUM CHANNELS;

EID: 85002919122     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13596     Document Type: Article

References (36)

1. Zara F, Specchio N, Striano P, et al. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance. Epilepsia 2013;54:425–436.
2. Maeda T, Shimizu M, Sekiguchi K, et al. Exacerbation of benign familial neonatal epilepsy induced by massive doses of phenobarbital and midazolam. Pediatr Neurol 2014;51:259–261.
3. Grinton BE, Heron SE, Pelekanos JT, et al. Familial neonatal seizures in 36 families: clinical and genetic features correlate with outcome. Epilepsia 2015;56:1071–1080.
4. Nash KB, Bonifacio SL, Glass HC, et al. Video-EEG monitoring in newborns with hypoxic-ischemic encephalopathy treated with hypothermia. Neurology 2011;76:556–562.
5. Soldovieri MV, Cilio MR, Miceli F, et al. Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions. J Neurosci 2007;27:4919–4928.
6. Soldovieri MV, Boutry-Kryza N, Milh M, et al. Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A. Hum Mutat 2014;35:356–367.
7. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res 2001;11:863–874.
8. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 2003;31:3812–3814.
9. Kurahashi H, Wang JW, Ishii A, et al. Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures. Neurology 2009;73:1214–1217.
10. Heron SE, Cox K, Grinton BE, et al. Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures. J Med Genet 2007;44:791–796.
11. Hirose S, Zenri F, Akiyoshi H, et al. A novel mutation of KCNQ3 (c.925T–>C) in a Japanese family with benign familial neonatal convulsions. Ann Neurol 2000;47:822–826.
12. Sugiura Y, Nakatsu F, Hiroyasu K, et al. Lack of potassium current in W309R mutant KCNQ3 channel causing benign familial neonatal convulsions (BFNC). Epilepsy Res 2009;84:82–85.
13. Uehara A, Nakamura Y, Shioya T, et al. Altered KCNQ3 potassium channel function caused by the W309R pore-helix mutation found in human epilepsy. J Membr Biol 2008;222:55–63.
14. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676–685.
15. Foldvary N, Klem G, Hammel J, et al. The localizing value of ictal EEG in focal epilepsy. Neurology 2001;57:2022–2028.
16. Connolly MB, Langill L, Wong PK, et al. Seizures involving the supplementary sensorimotor area in children: a video-EEG analysis. Epilepsia 1995;36:1025–1032.
17. Vigevano F, Fusco L, Di Capua M, et al. Benign infantile familial convulsions. Eur J Pediatr 1992;151:608–612.
18. Scheffer IE, Bhatia KP, Lopes-Cendes I, et al. Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet 1994;343:515–517.
19. Miceli F, Soldovieri MV, Lugli L, et al. Neutralization of a unique, negatively-charged residue in the voltage sensor of K V 7.2 subunits in a sporadic case of benign familial neonatal seizures. Neurobiol Dis 2009;34:501–510.
20. Singh B, Singh P, Al Hifzi I, et al. Treatment of neonatal seizures with carbamazepine. J Child Neurol 1996;11:378–382.
21. Hoppen T, Elger CE, Bartmann P. Carbamazepine in phenobarbital-nonresponders: experience with ten preterm infants. Eur J Pediatr 2001;160:444–447.
22. Pisano T, Numis AL, Heavin SB, et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia 2015;56:685–691.
23. Numis AL, Angriman M, Sullivan JE, et al. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response. Neurology 2014;82:368–370.
24. Pan Z, Kao T, Horvath Z, et al. A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon. J Neurosci 2006;26:2599–2613.
25. Howell KB, McMahon JM, Carvill GL, et al. SCN2A encephalopathy: a major cause of epilepsy of infancy with migrating focal seizures. Neurology 2015;85:958–966.
26. Larsen J, Carvill GL, Gardella E, et al. The phenotypic spectrum of SCN8A encephalopathy. Neurology 2015;84:480–489.
27. Boerma RS, Braun KP, van de Broek MP, et al. Remarkable phenytoin sensitivity in 4 children with SCN8A-related epilepsy: a molecular neuropharmacological approach. Neurotherapeutics 2016;13:192–197.
28. Matsufuji H, Ichiyama T, Isumi H, et al. Low-dose carbamazepine therapy for benign infantile convulsions. Brain Dev 2005;27:554–557.
29. Marini C, Conti V, Mei D, et al. PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology 2012;79:2109–2114.
30. Holmes GL. The long-term effects of neonatal seizures. Clin Perinatol 2009;36:901–914, vii-viii.
31. Glass HC, Hong KJ, Rogers EE, et al. Risk factors for epilepsy in children with neonatal encephalopathy. Pediatr Res 2011;70:535–540.
32. Cilio MR, Sogawa Y, Cha BH, et al. Long-term effects of status epilepticus in the immature brain are specific for age and model. Epilepsia 2003;44:518–528.
33. Ishii A, Miyajima T, Kurahashi H, et al. KCNQ2 abnormality in BECTS: benign childhood epilepsy with centrotemporal spikes following benign neonatal seizures resulting from a mutation of KCNQ2. Epilepsy Res 2012;102:122–125.
34. Neubauer BA, Waldegger S, Heinzinger J, et al. KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes. Neurology 2008;71:177–183.
35. Fusco C, Frattini D, Bassi MT. A novel KCNQ3 gene mutation in a child with infantile convulsions and partial epilepsy with centrotemporal spikes. Eur J Paediatr Neurol 2015;19:102–103.
36. Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 2002;99:15089–15094.